Shandong Risen-Sun Pharmaceutical Co. LTD is a pharmaceutical company established in 2013. It operates as a wholly-owned subsidiary of Jewim Pharmaceutical (Shandong) Co., Ltd,. established in 1993 and is the Largest pMDI manufacturer and exporter in China.
Risen-Sun has two factories: a high-tech plant (derived from Jewim separation) and the Ningyang plant. The first phase of the Ningyang plant project began construction in 2021 and was completed in 2023.
Risen-Sun focuses on the production, research and development, customization of characteristic APIs and advanced pharmaceutical intermediates. specialising in areas including respiratory system, mental system, glucocorticoid, and antineoplastic drugs.
Their commitment to innovation and quality positions them as a respected pharmaceutical enterprise with professional competitive advantage and international competitiveness.
